Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Myeloma Heterogeneity within Its Complex Immune Ecosystem

Jana Jakubikova, PhD, Danka Cholujova, PhD, Gabor Beke, PhD, Zachary R Hunter, PhD, Teru Hideshima, MD PhD, Merav Leiba, MD, Krzysztof Jamroziak, MD PhD, Paul G. Richardson, MD, Eftathios Kastritis, David M. Dorfman, MD PhD, Kenneth C. Anderson, MD

Blood (2019) 134 (Supplement_1): 4354.

https://doi.org/10.1182/blood-2019-132193

Published: 2019

Journal Articles

Predictive Significance of Selected Gene Mutations Identified Using Next Generation Sequencing in Relapsed and Refractory Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib

Marcin M Machnicki, MSc, Patryk Górniak, Monika Pepek, MSc, Agnieszka Szymczyk, Elżbieta Iskierka-Jażdżewska, Pawel Steckiewicz, Aleksandra Bluszcz, Malgorzata Rydzanicz, PhD, Marek Hus, Rafal Ploski, MD PhD, Przemyslaw Juszczynski, Prof., MD PhD, Tomasz Stoklosa, MD PhD, Krzysztof Jamroziak, MD PhD, Bartosz Pula

Blood (2019) 134 (Supplement_1): 5456.

https://doi.org/10.1182/blood-2019-124693

Published: 2019

Journal Articles

Analysis of Predictive Factors for Early Response to Ruxolitinib in 266 Patients with Myelofibrosis from the Polish Adult Leukemia Group (PALG) Registry

Blood (2019) 134 (Supplement_1): 4180.

https://doi.org/10.1182/blood-2019-125864

Published: 2019

Journal Articles

OP201: A Phase 1/2 Study of Melflufen and Dexamethasone in Patients with Immunoglobulin Light Chain (AL) Amyloidosis

Giovanni Palladini, MD PhD, Stefan O. Schönland, MD, Suzanne Lentzsch, MD PhD, M. Teresa Cibeira, MD PhD, Roman Hajek, Prof, MD PhD, Arnaud Jaccard, MD PhD, Krzysztof Jamroziak, MD PhD, Eftathios Kastritis, Vaishali Sanchorawala, MD, Fredrik H. Schjesvold, MD PhD, Ashutosh D Wechalekar, MBBS, MD FRCP, FRCPath, DM, Sara Thuresson, MSc, Johan Harmenberg, MD PhD, Catriona Byrne, RN, Giampaolo Merlini, MD

Blood (2019) 134 (Supplement_1): 3163.

https://doi.org/10.1182/blood-2019-124244

Published: 2019

Journal Articles

Type 2 Diabetes-Related Variants Influence on the Risk of Developing Multiple Myeloma: Results from the Immense Consortium

Blood (2014) 124 (21): 2044.

https://doi.org/10.1182/blood.V124.21.2044.2044

Published: 2014

Journal Articles

Impact of Drug Transporters ABCB1 and ABCG2 and Regulators of Xenobiotic Transport and Metabolism Pxr and CAR Gene Polymorphisms on Clinical Efficacy of Imatinib in Chronic Myeloid Leukemia (CML)

Anna Stepien, MSc, Alessandro Martino, PhD, Federico Canzian, PhD, Daniele Campa, PhD, Angelika Stein, Joanna Gora-Tybor, MD PhD, Tomasz Sacha, MD PhD, Dorota Link-Lenczowska, PhD, Izabela Florek, PhD, Witold Prejzner, MD PhD, Zofia Specht-Szwoch, Malgorzata Calbecka, MD PhD, Marcin Rymko, MD PhD, Marek Dudzinski, MD PhD, Pawel Gaj, PhD, Tadeusz Robak, MD, Krzysztof Warzocha, MD PhD, Krzysztof Jamroziak, MD PhD

Blood (2014) 124 (21): 5222.

https://doi.org/10.1182/blood.V124.21.5222.5222

Published: 2014

Journal Articles

The International Multiple Myeloma Research (IMMEnSE) Consortium: Genetics of Multiple Myeloma Risk and Prognosis

Blood (2014) 124 (21): 3421.

https://doi.org/10.1182/blood.V124.21.3421.3421

Published: 2014

Journal Articles

Cereblon ( CRBN) Gene Polymorphisms Predict Clinical Response and Progression-Free Survival in Multiple Myeloma Patients Treated with Lenalidomide: A Pharmacogenetic Study of Immense Consortium

Blood (2014) 124 (21): 3628.

https://doi.org/10.1182/blood.V124.21.3628.3628

Published: 2014

Journal Articles

High Expression Of Cereblon ( CRBN ) Is Associated With Achievement Of Complete Response To Thalidomide Plus Fludarabine Regimen In Chronic Lymphocytic Leukemia

Krzysztof Jamroziak, MD, PhD, Janusz Szemraj, PhD, Tadeusz Robak, MD, PhD, Krzysztof Giannopoulos, MD, PhD

Blood (2013) 122 (21): 4934.

https://doi.org/10.1182/blood.V122.21.4934.4934

Published: 2013

Journal Articles

A Randomized, Multicenter Study (PALG CLL4/ ML 21283) Of Maintenance Treatment With Rituximab Versus Observation After Induction Treatment With Rituximab, Cladribine, and Cyclophosphamide (RCC) Regimen In Patients With Progressive Chronic Lymphocytic Leukemia: Interim Analysis

Tadeusz Robak, Jerzy Z. Blonski, MD, PhD, Krzysztof Jamroziak, MD, PhD, Aleksander Skotnicki, Professor, Magdalena Piotrowska, MD, Anatoly Uss, Professor, Janusz Kloczko, Professor, Jaroslaw Piszcz, Kazimierz Kuliczkowski, Professor, Tomasz Wrobel, MD PhD, Bozena Katarzyna Budziszewska, MD, PhD, Marta Fidecka, Piotr Smolewski, Professor

Blood (2013) 122 (21): 1640.

https://doi.org/10.1182/blood.V122.21.1640.1640

Published: 2013

Journal Articles

Polymorphism Of CD44 Influences Efficacy Of CD34+Cells Mobilization In Patients With Hematological Malignancies

Anna Szmigielska-Kaplon, MD, PhD, Janusz Szemraj, PhD, Krzysztof Jamroziak, MD, PhD, Agnieszka Pluta, MD, PhD, Marta Robak, PhD, Anna Krawczynska, PhD, Katarzyna Hamara, MS, Katarzyna Szmigielska, MD, PhD, Tadeusz Robak, Agnieszka Wierzbowska, MD, PhD

Blood (2013) 122 (21): 3270.

https://doi.org/10.1182/blood.V122.21.3270.3270

Published: 2013

Journal Articles

Real-Life Comparison Of Severe Vascular Events and Other Non-Hematological Complications In CML Patients Treated With Second Line Nilotinib Or Dasatinib

Joanna Gora-Tybor, MD, PhD, Ewa Medras, MD, PhD, Malgorzata Calbecka, MD, PhD, Agnieszka Kolkowska, MD, Edyta Ponikowska-Szyba, MD, Tadeusz Robak, MD, PhD, Krzysztof Jamroziak, MD, PhD

Blood (2013) 122 (21): 1491.

https://doi.org/10.1182/blood.V122.21.1491.1491

Published: 2013

Journal Articles

CD38 Gene Polymorphisms Contribute to Genetic Predisposition to B-Cell Chronic Lymphocytic Leukemia.

Krzysztof Jamroziak, MD, PhD, Zofia Szemraj, Olga Grzybowska-Izydorczyk, MD, Janusz Szemraj, PhD, Barbara Cebula, PhD, Ewa Balcerczak, PhD, Ewa Wawrzyniak, PhD, Marek Mirowski, PhD, Tadeusz Robak, MD, PhD

Blood (2007) 110 (11): 491.

https://doi.org/10.1182/blood.V110.11.491.491

Published: 2007

Journal Articles

Influence of High Expression of p73 and p53 Proteins on Clinical Outcome in Acute Myeloid Leukemia Patients.

Agnieszka Pluta, MD, PhD, Piotr Smolewski, Agnieszka Wierzbowska, MD, PhD, Barbara Cebula, PhD, Krzysztof Jamroziak, MD, PhD, Tadeusz Robak

Blood (2007) 110 (11): 4306.

https://doi.org/10.1182/blood.V110.11.4306.4306

Published: 2007

Journal Articles

Pharmacogenetics of Response to Glucocorticosteroids in Adults with Acute Lymphoblastic Leukemia.

Krzysztof Jamroziak, MD, PhD, Ewa Balcerczak, PhD, Zofia Szemraj, Aleksandra Salagacka, Olga Grzybowska-Izydorczyk, MD, Barbara Cebula, PhD, Janusz Szemraj, PhD, Marek Mirowski, PhD, Tadeusz Robak, MD,PhD

Blood (2006) 108 (11): 2609.

https://doi.org/10.1182/blood.V108.11.2609.2609

Published: 2006

Journal Articles

The VH3-21 Gene Status Correlates with Elevated β2-Microglobulin Serum Levels and Shorter Overall Survival of Patients with Chronic Lymphocytic Leukemia.

Ewa Lech-Maranda, MD, PhD, Tadeusz Robak, MD, PhD, Anna Szmigielska-Kaplon, MD, PhD, Hanna Makuch-Lasica, MD, Iwona Solarska, MD, Krzysztof Jamroziak, MD, PhD, Ewa Balcerczak, MD, PhD, Marek Mirowski, MD, PhD, Miroslaw P. Majewski, MD, PhD, Krzysztof Warzocha, MD, PhD

Blood (2005) 106 (11): 4988.

https://doi.org/10.1182/blood.V106.11.4988.4988

Published: 2005

Journal Articles

Pharmacogenetic Analysis of Polymorphisms in Pharmacological Pathway of Vincristine, Doxorubicine and Dexamethasone (VAD Regimen) To Predict Response in Patients with Multiple Myeloma.

Krzysztof Jamroziak, MD, PhD, Ewa Balcerczak, PhD, Mariusz Panczyk, Sylwester Piaskowski, Agnieszka Janus, MD, Barbara Cebula, Marek Mirowski, PhD, Piotr Smolewski, MD, PhD, Halina Urbanska-Rys, MD, PhD, Piotr Cichocki, Tadeusz Robak, MD, PhD

Blood (2005) 106 (11): 104.

https://doi.org/10.1182/blood.V106.11.104.104

Published: 2005

Journal Articles

Analysis of Common Single Nucleotide Polymorphisms in MDR1 Gene in Patients with Multiple Myeloma.

Krzysztof Jamroziak, MD, PhD, Ewa Balcerczak, PhD, Piotr Smolewski, MD, PhD, Sylwester Piaskowski, PhD, Barbara Cebula, Mariusz Panczyk, Agnieszka Janus, Marek Mirowski, PhD, Tadeusz Robak, MD, PhD

Blood (2004) 104 (11): 4371.

https://doi.org/10.1182/blood.V104.11.4371.4371

Published: 2004

NARROW

Myeloma Heterogeneity within Its Complex Immune Ecosystem

Predictive Significance of Selected Gene Mutations Identified Using Next Generation Sequencing in Relapsed and Refractory Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib

Analysis of Predictive Factors for Early Response to Ruxolitinib in 266 Patients with Myelofibrosis from the Polish Adult Leukemia Group (PALG) Registry

OP201: A Phase 1/2 Study of Melflufen and Dexamethasone in Patients with Immunoglobulin Light Chain (AL) Amyloidosis

Type 2 Diabetes-Related Variants Influence on the Risk of Developing Multiple Myeloma: Results from the Immense Consortium

Impact of Drug Transporters ABCB1 and ABCG2 and Regulators of Xenobiotic Transport and Metabolism Pxr and CAR Gene Polymorphisms on Clinical Efficacy of Imatinib in Chronic Myeloid Leukemia (CML)

The International Multiple Myeloma Research (IMMEnSE) Consortium: Genetics of Multiple Myeloma Risk and Prognosis

Cereblon ( CRBN) Gene Polymorphisms Predict Clinical Response and Progression-Free Survival in Multiple Myeloma Patients Treated with Lenalidomide: A Pharmacogenetic Study of Immense Consortium

High Expression Of Cereblon ( CRBN ) Is Associated With Achievement Of Complete Response To Thalidomide Plus Fludarabine Regimen In Chronic Lymphocytic Leukemia

A Randomized, Multicenter Study (PALG CLL4/ ML 21283) Of Maintenance Treatment With Rituximab Versus Observation After Induction Treatment With Rituximab, Cladribine, and Cyclophosphamide (RCC) Regimen In Patients With Progressive Chronic Lymphocytic Leukemia: Interim Analysis

Polymorphism Of CD44 Influences Efficacy Of CD34+Cells Mobilization In Patients With Hematological Malignancies

Real-Life Comparison Of Severe Vascular Events and Other Non-Hematological Complications In CML Patients Treated With Second Line Nilotinib Or Dasatinib

CD38 Gene Polymorphisms Contribute to Genetic Predisposition to B-Cell Chronic Lymphocytic Leukemia.

Influence of High Expression of p73 and p53 Proteins on Clinical Outcome in Acute Myeloid Leukemia Patients.

Pharmacogenetics of Response to Glucocorticosteroids in Adults with Acute Lymphoblastic Leukemia.

The VH3-21 Gene Status Correlates with Elevated β2-Microglobulin Serum Levels and Shorter Overall Survival of Patients with Chronic Lymphocytic Leukemia.

Pharmacogenetic Analysis of Polymorphisms in Pharmacological Pathway of Vincristine, Doxorubicine and Dexamethasone (VAD Regimen) To Predict Response in Patients with Multiple Myeloma.

Analysis of Common Single Nucleotide Polymorphisms in MDR1 Gene in Patients with Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only